TEST:

UriFind® Methylation Test

UriFind®️, is based on the high-throughput sequencing data of Chinese bladder cancer patient samples, combined with the TCGA database, to screen out bladder cancer-specific methylation sites, and statistically analyze thousands of cases The test results of urine samples of clinical patients in the United States have constructed a bladder cancer diagnosis model. UriFind®️can accurately detect bladder cancer by detecting urine samples of the subject, effectively overcoming the limitations of conventional diagnostic methods and improving the diagnostic level of bladder cancer.